Literature DB >> 21281255

Increase of regulatory T cells in ileal mucosa of untreated pediatric Crohn's disease patients.

Dag Henrik Reikvam1, Gøri Perminow, Lars Gustav Lyckander, Jon Michael Gran, Per Brandtzaeg, Morten Vatn, Hege S Carlsen.   

Abstract

BACKGROUND: Inflammatory bowel disease (IBD) of pediatric and adult onset differs in several aspects although little knowledge exists about pathogenic disparity. Regulatory T cells (Tregs) characterized as CD4+CD25+Foxp3+ are modulators of gut homeostasis, but their role in human IBD remains unclear.
OBJECTIVE: To evaluate the mucosal distribution of Foxp3+ and CD25+ cells in untreated pediatric IBD patients at the time of diagnosis.
MATERIAL AND METHODS: Untreated pediatric (n = 14) and adult (n = 12) Crohn's disease (CD) patients were prospectively included together with age-matched symptomatic controls. Colonic and ileal mucosal biopsies collected at diagnosis were studied by immunohistochemistry for enumeration of T cells and for mucosal expression of Foxp3 and CD25. Multicolor immunofluorescence staining was performed in situ to phenotype Foxp3+ cells as Tregs and characterize the CD25+ cells.
RESULTS: The density of mucosal T cells displayed only small variations, while that of Foxp3+ cells and CD25+ cells was increased in CD patients. Multicolor immunofluorescence showed that most CD25+ cells were macrophages. Interestingly, in the ileum of pediatric CD patients the density of Foxp3+ cells was significantly higher than in adult CD patients. Co-expression of Foxp3 and CD25, as well as Foxp3 and CTLA-4, indicated that the Foxp3+ cells were Tregs.
CONCLUSION: Mucosal numbers of Foxp3(+) Tregs and activated (CD25+) macrophages are elevated in both pediatric and adult ileal CD. The greater increase of ileal Foxp3+ Tregs in pediatric CD than in adult CD might contribute to the relatively less frequent phenotype of isolated ileal enteritis in CD children.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21281255     DOI: 10.3109/00365521.2011.551887

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  16 in total

Review 1.  Regulatory T-cell therapy for inflammatory bowel disease: more questions than answers.

Authors:  Megan E Himmel; Yu Yao; Paul C Orban; Theodore S Steiner; Megan K Levings
Journal:  Immunology       Date:  2012-06       Impact factor: 7.397

2.  Amelioration of experimental colitis after short-term therapy with glucocorticoid and its relationship to the induction of different regulatory markers.

Authors:  Helioswilton Sales-Campos; Patrícia R de Souza; Paulo J Basso; Viviani Nardini; Angelica Silva; Fernanda Banquieri; Vanessa B F Alves; Javier E L Chica; Auro Nomizo; Cristina R B Cardoso
Journal:  Immunology       Date:  2016-10-07       Impact factor: 7.397

Review 3.  Muramyl dipeptide responsive pathways in Crohn's disease: from NOD2 and beyond.

Authors:  Mohammad Salem; Jakob Benedict Seidelin; Gerhard Rogler; Ole Haagen Nielsen
Journal:  Cell Mol Life Sci       Date:  2012-12-29       Impact factor: 9.261

4.  Intestinal Regulatory T Cells.

Authors:  Vanessa R Figliuolo da Paz; Deepa R Jamwal; Pawel R Kiela
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Persistent infection with Crohn's disease-associated adherent-invasive Escherichia coli leads to chronic inflammation and intestinal fibrosis.

Authors:  Cherrie-Lee N Small; Sarah A Reid-Yu; Joseph B McPhee; Brian K Coombes
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

6.  Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's disease.

Authors:  James B Canavan; Cristiano Scottà; Anna Vossenkämper; Rimma Goldberg; Matthew J Elder; Irit Shoval; Ellen Marks; Emilie Stolarczyk; Jonathan W Lo; Nick Powell; Henrieta Fazekasova; Peter M Irving; Jeremy D Sanderson; Jane K Howard; Simcha Yagel; Behdad Afzali; Thomas T MacDonald; Maria P Hernandez-Fuentes; Nahum Y Shpigel; Giovanna Lombardi; Graham M Lord
Journal:  Gut       Date:  2015-02-24       Impact factor: 23.059

7.  Transcriptional risk scores link GWAS to eQTLs and predict complications in Crohn's disease.

Authors:  Urko M Marigorta; Lee A Denson; Jeffrey S Hyams; Kajari Mondal; Jarod Prince; Thomas D Walters; Anne Griffiths; Joshua D Noe; Wallace V Crandall; Joel R Rosh; David R Mack; Richard Kellermayer; Melvin B Heyman; Susan S Baker; Michael C Stephens; Robert N Baldassano; James F Markowitz; Mi-Ok Kim; Marla C Dubinsky; Judy Cho; Bruce J Aronow; Subra Kugathasan; Greg Gibson
Journal:  Nat Genet       Date:  2017-08-14       Impact factor: 38.330

8.  Age-dependent fecal bacterial correlation to inflammatory bowel disease for newly diagnosed untreated children.

Authors:  Felix Chinweije Nwosu; Lill-Therse Thorkildsen; Ekaterina Avershina; Petr Ricanek; Gøri Perminow; Stephan Brackmann; Morten H Vatn; Knut Rudi
Journal:  Gastroenterol Res Pract       Date:  2013-04-18       Impact factor: 2.260

9.  Prolactin mediates psychological stress-induced dysfunction of regulatory T cells to facilitate intestinal inflammation.

Authors:  Wei Wu; Mingming Sun; Huan-Ping Zhang; Tengfei Chen; Ruijin Wu; Changqin Liu; Gui Yang; Xiao-Rui Geng; Bai-Sui Feng; Zhigang Liu; Zhanju Liu; Ping-Chang Yang
Journal:  Gut       Date:  2014-02-18       Impact factor: 23.059

10.  Regulatory T cells in Crohn's disease following anti-TNF-α therapy.

Authors:  Toshimi Chiba; Mikiya Endo; Shoko Miura; Yuko Hayashi; Yoshiko Asakura; Kotaro Oyama; Takayuki Matsumoto
Journal:  JGH Open       Date:  2019-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.